AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 272 min read$TDOC

Teladoc (TDOC) reports Q3: everything you need to know ahead of earnings

Teladoc Health (TDOC) is set to report Q3 earnings, with analysts expecting a 6.1% year-on-year revenue decline. The company missed revenue expectations last quarter, reporting $606.9 million, down 4% year on year. Analysts have generally reconfirmed their estimates, and Teladoc's stock is up 6.1% over the last month, with an average price target of $7.47.

Original reporting
finance.yahoo.com
Published Oct 27, 2026, 3:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 3:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Teladoc (TDOC) reports Q3: everything you need to know ahead of earnings — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TDOCBearishLow
01

Why it matters

The preview offers little new data; traders should treat it as a reminder of existing weakness rather than a catalyst.

02

Market read

The piece is a low‑novelty earnings preview with no fresh information, resulting in limited trading relevance.

03

What to watch

Potential cost‑cutting measures or new partnership announcements not covered in the recap.

Relevance 4/10Novelty 2/10Timing: pre‑market on earnings day

Background

Teladoc Health (TDOC) is set to report Q3 results. The article repeats prior quarter numbers and notes that revenue guidance missed expectations.

Company-level read

Ticker impact

$TDOCBearishMedium confidence
Context

The article previews Teladoc's upcoming earnings, noting the prior quarter missed revenue expectations and guidance fell short of analysts' forecasts.

Expected impact

downward pressure as the market prices in the revenue miss and weak guidance

Evidence & confidence

Recap of already‑public Q3 results and guidance suggests no surprise; investors typically react negatively to repeated misses.

Market effects

Sector

Consumer internet and digital health peers may see modest impact as Teladoc's performance reflects sector demand trends.

Regional

U.S. market sentiment toward telehealth stocks could soften ahead of earnings season.

Global

Limited; primarily affects U.S. listed telehealth equities.

Counterpoint

What could challenge this read

If Teladoc can exceed guidance, the stock may rally on a surprise beat.

Key entities

  • company
    Teladoc Health

    U.S.-listed digital medical services platform.

Read at source← All news

Related articles

SEP 28
$TDOCMed

Why is Teladoc stock sliding today?

Teladoc (TDOC) shares fell 2.3% to $5.95 amid leadership transition concerns. The company's CLO resigned, raising governance questions. The stock has declined since Q2 revenue missed expectations and guidance was cut. Analysts have lowered price targets, and institutional selling has increased. The broader market's decline added pressure. TDOC trades near its 52-week low of $4.40.

investing.com2 min
SEP 1
$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

yahoo.com2 min
AUG 31
$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

wncy.com2 min
AUG 8
$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

aol.com6 min